Remote electrical stimulation is an effective, noninvasive, nonpharmacologic alternative treatment to traditional medications for acute migraine.
While it requires further validation, copeptin may serve as a novel biomarker to help rule out serious secondary headache.
Patients with chronic migraine and comorbidities incur nearly 2 times the health care costs of patients with migraine alone.
Reward feedback responses in the brain may be predictive of chronic pain complaints later on.
The FDA released guidance to establish standards for communications about products.
Novel psychosocial therapies such as cognitive behavioral therapy that have been effective in adults with fibromyalgia need additional neuromuscular fitness training to overcome catastrophizing and fear of exercise in adolescents.
Cognitive behavioral therapy is an effective nonpharmacologic treatment that should be considered as a first-line therapy for pediatric migraine.